New Key Statistics Module, Z-Score and F-Score
NAS:ACAD Key Ratios
| Market Cap $ M | 4,828.00 |
| Enterprise Value $ M | 3,945.38 |
| P/E(ttm) | 12.62 |
| PE Ratio without NRI | 12.62 |
| Forward PE Ratio | 30.83 |
| Price/Book | 3.69 |
| Price/Sales | 4.24 |
| Price/Free Cash Flow | 33.20 |
| Price/Owner Earnings | 13.87 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,138.00 |
| EPS (TTM) $ | 2.22 |
| Beneish M-Score | -1.25 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -7.70 |
| EV-to-EBIT | 45.68 |
| EV-to-EBITDA | 40.10 |
| PEG | -- |
| Shares Outstanding M | 172.31 |
| Net Margin (%) | 33.42 |
| Operating Margin % | 7.59 |
| Pre-tax Margin (%) | 10.66 |
| Quick Ratio | 3.30 |
| Current Ratio | 3.39 |
| ROA % (ttm) | 25.47 |
| ROE % (ttm) | 34.45 |
| ROIC % (ttm) | 18.86 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.65 |
ACAD Number of Guru Trades
ACAD Volume of Guru Trades
Gurus Latest Trades with NAS:ACAD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ACAD is held by these investors
Total 1
ACADIA Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ACAD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers